Drug Shortage Report for BIPHENTIN
Report ID | 183524 |
Drug Identification Number | 02277190 |
Brand name | BIPHENTIN |
Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 50MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 50 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2023-02-02 |
Actual start date | 2023-02-02 |
Estimated end date | 2023-04-05 |
Actual end date | 2023-04-04 |
Shortage status | Resolved |
Updated date | 2023-04-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2023-04-05 | English | Compare |